Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/28/2002DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/28/2002DE10121771A1 Verfahren zum Betreiben eines Sensorelements Method for operating a sensor element
11/28/2002DE10105581C1 Resistive gallium oxide-hydrogen sensor comprises a gas-sensitive layer with measuring structure and containing gallium oxide
11/28/2002DE10053250A1 Oil state sensor device e.g. for motor vehicle oil derives various parameters of oil condition from output of ultrasonic sensor
11/28/2002CA2741544A1 Semen analysis
11/28/2002CA2487099A1 Methods for selecting and producing animals having a predicted level of immune response
11/28/2002CA2457853A1 Benzophenone-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor (crf) binding protein
11/28/2002CA2450677A1 A novel intein and uses thereof
11/28/2002CA2448668A1 Modulation of cd200 receptors
11/28/2002CA2448534A1 Peptide analysis using a solid support
11/28/2002CA2448253A1 Human cdnas and proteins and uses thereof
11/28/2002CA2448185A1 Method for identifying micro-organisms using mass spectrometry
11/28/2002CA2448180A1 Immobilized asymmetric double lipid layers
11/28/2002CA2448165A1 Pyruvate-kinase as a novel target molecule
11/28/2002CA2448142A1 Beta-secretase substrates and uses thereof
11/28/2002CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002CA2448045A1 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002CA2448018A1 Compositions and methods for inhibiting metastasis
11/28/2002CA2448014A1 Tsg101 as inhibitor of hiv production
11/28/2002CA2447942A1 A gene and uses therefor
11/28/2002CA2447823A1 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
11/28/2002CA2447799A1 Emission ratiometric indicators of phosphorylation
11/28/2002CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002CA2447612A1 Selection of target sites for antisense attack of rna
11/28/2002CA2447581A1 A urine collection device
11/28/2002CA2447340A1 Kinases and phosphatases
11/28/2002CA2447338A1 Receptors and membrane-associated proteins
11/28/2002CA2447336A1 Methods of detecting protein arginine methyltransferase, and uses related thereto
11/28/2002CA2447323A1 Method of examining and diagnosing skin health
11/28/2002CA2447313A1 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002CA2447215A1 Adherent entities and uses therefor
11/28/2002CA2447161A1 Conjugates and compositions for cellular delivery
11/28/2002CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002CA2445053A1 Methods and compositions for analyzing proteins
11/28/2002CA2444407A1 System for cellular storage and genetic information retrieval
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2441666A1 Phytases, nucleic acids encoding them and methods and using them
11/28/2002CA2440147A1 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
11/28/2002CA2435535A1 Immunoassay
11/27/2002EP1260927A2 Information processing system using nucleotide sequence-related information
11/27/2002EP1260817A2 Method for direct measurement of coagulation factor VIIa activity in plasma
11/27/2002EP1260816A1 Method of examining allergic diseases
11/27/2002EP1260815A2 Methods for automatically monitoring analyte concentration using minimally invasive devices
11/27/2002EP1260814A2 Gas sensor and method for measuring gas concentration using the same
11/27/2002EP1260813A1 System of electrodes for an electrochemical sensor
11/27/2002EP1260807A1 Consumable for laser capture microdissection
11/27/2002EP1260595A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
11/27/2002EP1260591A1 High-efficiency assay for protein mannosyl transferases
11/27/2002EP1260590A1 Method of screening substance specifically inhibiting non-mevalonate pathway
11/27/2002EP1260589A2 Biosensor
11/27/2002EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002EP1260585A1 Novel protein and gene encoding the same
11/27/2002EP1260583A1 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample
11/27/2002EP1260521A2 Immunoglobulin variants for specific Fc epsilon receptors
11/27/2002EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002EP1260476A1 Yarn quality control method
11/27/2002EP1260265A1 Apparatus for the preparation of a hybridisation chamber, processing set and system for the hybridisation of samples of nucleic acid, proteines and tissues
11/27/2002EP1260229A2 Anti-autoimmune composition comprising inhibitors of growth hormone-releasing factor activity
11/27/2002EP1259946A2 Cellular telephone interactive wagering system
11/27/2002EP1259928A2 Process for estimating random error in chemical and biological assays
11/27/2002EP1259827A2 Biosynthetic carbohydrate-deficient transferrin references
11/27/2002EP1259826A1 Biological or chemical testing device
11/27/2002EP1259825A2 Method for carrying out the differential diagnostic determination of autoantibodies formed against the tsh receptor in a serum sample or plasma sample of a patient
11/27/2002EP1259824A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers
11/27/2002EP1259822A2 Method of identifying modulators of presenilin
11/27/2002EP1259821A1 Method of identifying modulators of presenilin
11/27/2002EP1259820A2 Method for analysis of substances in tissue or in cells
11/27/2002EP1259819A2 Diagnosis of bipolar affective disorder (bad) and unipolar depression
11/27/2002EP1259816A2 Prediction of hepatic failure following hepatitis c
11/27/2002EP1259815A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma
11/27/2002EP1259814A1 Bcmp-7 as marker for diagnosis of breast cancer
11/27/2002EP1259813A2 Diagnosis and treatment of malignant neoplasms
11/27/2002EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002EP1259811A2 Diagnostic agent for chemotaxis
11/27/2002EP1259810A2 Analytical measuring and evaluation method for molecular interactions
11/27/2002EP1259809A1 Biosensors, method for obtaining same and uses thereof
11/27/2002EP1259808A2 Method for labeling individual cells
11/27/2002EP1259807A1 Personal computer breath analyzer for health-related behavior modification and method
11/27/2002EP1259806A1 Electrical impedance measuring method for differentiating tissue types
11/27/2002EP1259805A1 Lipoprotein assay
11/27/2002EP1259804A2 Non-destructive method for controlling wooden poles in particular electrical or telephone network poles
11/27/2002EP1259803A2 Method for operating a sensor
11/27/2002EP1259800A2 Enzymatic-electrochemical measuring device
11/27/2002EP1259793A2 Analytical sampling device
11/27/2002EP1259791A2 Method for non-invasive spectrophotometric blood oxygenation monitoring
11/27/2002EP1259714A2 Method for determining motor oil wear
11/27/2002EP1259650A2 Estrogen receptor alpha variants and methods of detection thereof
11/27/2002EP1259648A2 Diagnostics and therapeutics for glaucoma
11/27/2002EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002EP1259646A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination
11/27/2002EP1259644A2 Novel dna chips
11/27/2002EP1259643A2 Nucleic acid detection methods using universal priming
11/27/2002EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259640A2 Methods and compositions for the screening of cell cycle modulators
11/27/2002EP1259638A2 Methods for selectively modulating survivin apoptosis pathways
11/27/2002EP1259634A2 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
11/27/2002EP1259633A1 Device and electrode arrangement for electrophysiological investigations
11/27/2002EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators